Serum and gingival crevicular fluid levels of ciprofloxacin in patients with periodontitis

Journal of the American Dental Association

Volumn 135, Issue 12, 2004, Pages 1728-1732

  Tözüm, Tolga F ^a   Yildirim, Ayşegül ^a   Çaǧlayan, Feriha ^a   Dinçel, Aysun ^a   Bozkurt, Atilla ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; GINGIVITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PATIENT; PERIODONTITIS; SERUM; VENOUS BLOOD;

EID: 11844273880     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2004.0127     Document Type: Article

References (40)

1. The American Academy of Periodontology. Glossary of periodontal terms. 3rd ed. Chicago: American Academy of Periodontology; 2001:40.
2. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4(1):1-6.
3. Haake SK, Nisengard RJ, Newman MG, Miyasaki KT. Microbial interactions with the host in periodontal diseases. In: Newman MG, Takei HH, Carranza FA, eds. Carranza's clinical periodontology. Philadelphia: Saunders; 2002:132-52.
4. Bragd L, Dahlen G, Wikstrom M, Slots J. The capability of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius to indicate progressive periodontitis: a retrospective study. J Clin Periodontol 1987;14(2):95-9.
5. Conway TB, Beck FM, Walters JD. Gingival fluid ciprofloxacin levels at healthy and inflamed human periodontal sites. J Periodontol 2000;71:1448-52.
6. Goodson JM. Antimicrobial strategies for treatment of periodontal diseases. Periodontol 2000 1994;5(June):142-68.
7. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000 2002;28:106-76.
8. Bollen CM, Quirynen M. Microbiological response to mechanical treatment in combination with adjunctive therapy: a review of the literature. J Periodontol 1996;67:1143-58.
9. Tözüm TF, Berker E, Ersoy F, Tezcan I, Sanal O. The relationship between periodontal status and peripheral levels of neutrophils in two consanguineous siblings with severe congenital neutropenia: case reports. Quintessence Int 2003;34:221-6.
10. Müller HP, Holderrieth S, Burkhardt U, Höffler U. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics. J Clin Periodontol 2002;29:736-42.
11. Gordon JM, Walker CB, Goodson JM, Socransky SS. Sensitive assay for measuring tetracycline levels in gingival crevice fluid. Antimicrob Agents Chemother 1980;17(2):193-8.
12. Pascale D, Gordon J, Lamster I, Mann P, Seiger M, Arndt W. Concentration of doxycycline in human gingival fluid. J Clin Periodontol 1986;13:841-4.
13. Cacchillo DA, Walters JD. Effect of ciprofloxacin on killing of Actinobacillus actinomycetemcomitans by polymorphonuclear leukocytes. Antimicrob Agents Chemother 2002;46:1980-4.
14. Smith JA. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994;56:672-86.
15. Christersson LA, Albini B, Zambon JJ, Wikesjo UM, Genco RJ. Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis, I: light, immunofluorescence and electron microscopic studies. J Periodontol 1987;58:529-39.
16. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994;5(June):78-111.
17. Easmon CS, Crane JP. Uptake of ciprofloxacin by human neutrophils. J Antimicrob Chemother 1985;16(1):67-73.
18. van Rensburg CE, Joone G, Anderson R. Interactions of the oxygen-dependent antimicrobial system of the human neutrophil with difloxacin, ciprofloxacin, pefloxacin and fleroxacin in the intraphagocytic eradication of Staphylococcus aureus. J Med Microbiol 1990;32(1):15-7.
19. Löe H, Silness J. Periodontal disease in pregnancy, I: prevalence and severity. Acta Odontol Scand 1963;21:533-51.
20. Silness J, Löe H. Periodontal disease in pregnancy, II: correlation between oral hygiene and periodontal conditions. Acta Odontol Scand 1964;22(February):121-35.
21. Atici K, Yamalik N, Eratalay K, Etikan I. Analysis of gingival crevicular fluid intracytoplasmic enzyme activity in patients with adult periodontitis and rapidly progressive periodontitis: a longitudinal study model with periodontal treatment. J Periodontol 1998;69:1155-63.
22. Egelberg J, Attstrom R. Comparison between orifice and intracrevicular methods of sampling gingival fluid. J Periodontal Res 1973;8:384-8.
23. Deinzer R, Mossanen BS, Herforth A. Methodological considerations in the assessment of gingival crevicular fluid volume. J Clin Periodontol 2000;27:481-8.
24. Jim LK, el-Sayed N, al-Khamis KI. A simple high-performance liquid chromatographic assay for ciprofloxacin in human serum. J Clin Pharm Ther 1992;17(2):111-5.
25. Lavanchy DL, Bickel M, Baehni PC. The effect of plaque control after scaling and root planing on the subgingival microflora in human periodontitis. J Clin Periodontol 1987;14:295-9.
26. Adriaens PA, De Boever JA, Loesche WJ. Bacterial invasion in root cementum and radicular dentin of periodontally diseased teeth in humans: a reservoir of periodontopathic bacteria. J Periodontol 1988;59:222-30.
27. van Winkelhoff AJ, Rams TE, Slots J. Systemic antibiotic therapy in periodontics. Periodontol 2000 1996;10(February):45-78.
28. Gordon JM, Walker CB, Murphy JC, Goodson JM, Socransky SS. Concentration of tetracycline in human gingival fluid after single doses. J Clin Periodontol 1981;8(2):117-21.
29. Gordon JM, Walker CB, Murphy JC, Goodson JM, Socransky SS. Tetracycline: levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms, part I: concentrations in crevicular fluid after repeated doses. J Periodontol 1981;52:609-12.
30. Britt MR, Pohlod DJ. Serum and crevicular fluid concentrations after a single oral dose of metronidazole. J Periodontol 1986;57(2):104-7.
31. Liew V, Mack G, Tseng P, Cvejic M, Hayden M, Buchanan N. Single-dose concentrations of tinidazole in gingival crevicular fluid, serum, and gingival tissue in adults with periodontitis. J Dent Res 1991;70:910-2.
32. Olsvik B, Hansen BF, Tenover FC, Olsen I. Tetracycline-resistant micro-organisms recovered from patients with refractory periodontal disease. J Clin Periodontol 1995;22:391-6.
33. Wolfson JS, Hooper DC. Fluoroquinolone antimicrobial agents. Clin Microbiol Rev 1989;2:378-424.
34. Holm A, Kalfas S, Holm SE. Killing of Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus by human polymorphonuclear leukocytes in serum and saliva. Oral Microbiol Immunol 1993;8(3):134-40.
35. Slots J, Feik D, Rams TE. In vitro antimicrobial sensitivity of enteric rods and pseudomonads from advanced adult periodontitis. Oral Microbiol Immunol 1990;5:298-301.
36. Rams TE, Feik D, Young V, Hammond BF, Slots J. Enterococci in human periodontitis. Oral Microbiol Immunol 1992;7:249-52.
37. Pavicic MJ, van Winkelhoff AJ, de Graaff J. In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations. Antimicrob Agents Chemother 1992;36:2634-8.
38. Jacobs F, Marchal M, de Francquen P, Kains JP, Gangii D, Thys JP. Penetration of ciprofloxacin into human pleural fluid. Antimicrob Agents Chemother 1990;34:934-6.
39. Keren G, Alhalel A, Bartov E, et al. The intravitreal penetration of orally administered ciprofloxacin in humans. Invest Ophthalmol Vis Sci 1991;32:2388-92.
40. Fong IW, Ledbetter WH, Vandenbroucke AG, Simbul M, Rahm V. Ciprofloxacin concentrations in bone and muscle after oral dosing. Antimicrob Agents Chemother 1986;29:405-8.